Scarica l'app Stockscreener
15.83
0.51%
0.08
Dopo l'orario di chiusura:
15.83
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$15.75
Aprire:
$15.59
Volume 24 ore:
429.61K
Relative Volume:
0.67
Capitalizzazione di mercato:
$1.29B
Reddito:
$1.53B
Utile/perdita netta:
$40.23M
Rapporto P/E:
31.66
EPS:
0.5
Flusso di cassa netto:
$60.93M
1 W Prestazione:
-9.13%
1M Prestazione:
-31.53%
6M Prestazione:
-19.89%
1 anno Prestazione:
-50.44%
Intervallo 1D:
$15.46
$15.96
Intervallo di 1 settimana:
$15.46
$17.46
Portata 52W:
$15.46
$32.66
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Nome
Integra Lifesciences Holdings Corp
Settore
Industria
Telefono
(609) 275-0500
Indirizzo
1100 CAMPUS ROAD, PRINCETON, NJ
Confronta IART con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
15.83 | 1.29B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-31 | Aggiornamento | Argus | Hold → Buy |
| 2024-12-02 | Iniziato | Morgan Stanley | Underweight |
| 2024-10-07 | Aggiornamento | BTIG Research | Sell → Neutral |
| 2024-07-30 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-07-30 | Downgrade | Citigroup | Neutral → Sell |
| 2024-05-07 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-12-05 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Iniziato | CL King | Buy |
| 2023-08-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-08 | Downgrade | Argus | Buy → Hold |
| 2023-05-24 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Downgrade | Citigroup | Neutral → Sell |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-25 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2021-12-17 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Iniziato | Citigroup | Neutral |
| 2020-04-03 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Iniziato | SunTrust | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-08-07 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-07-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Iniziato | UBS | Buy |
Mostra tutto
Integra Lifesciences Holdings Corp Borsa (IART) Ultime notizie
Integra LifeSciences to Release First Quarter 2025 Financial Results on May 5, 2025 - Nasdaq
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 - Yahoo Finance
Geode Capital Management LLC Sells 247,336 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Arrowstreet Capital Limited Partnership Has $312,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Truist Adjusts Price Target for Integra LifeSciences (IART) Ahea - GuruFocus
Integra LifeSciences stock hits 52-week low at $16.76 - Investing.com
Integra LifeSciences stock hits 52-week low at $16.76 By Investing.com - Investing.com Canada
Attention Long-Term Shareholders of Axsome Therapeutics, - GlobeNewswire
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Sei Investments Co. - Defense World
Do Options Traders Know Something About Integra (IART) Stock We Don't? - Yahoo Finance
Norges Bank Acquires New Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Alert to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); General Motors Company (NYSE: GM); Integra LifeSciences Holdings Corporation (NASDAQ: IART); and ModivCare, Inc. (NASDAQ: MODV): Act Now as Grabar Law Office Is - GlobeNewswire
Orion Portfolio Solutions LLC Invests $728,000 in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
15,100 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Purchased by KLP Kapitalforvaltning AS - Defense World
Corebridge Financial Inc. Decreases Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Raymond James Financial Inc. Invests $943,000 in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Alert to Long-Term Shareholders of Driven Brands Holdings, - GlobeNewswire
Argus upgrades Integra to Buy, says well-positioned for a turnaround - Yahoo Finance
Integra LifeSciences (NASDAQ:IART) Rating Increased to Buy at Argus - Defense World
Argus raises Integra LifeSciences stock rating to buy, sets $28 target By Investing.com - Investing.com South Africa
Argus raises Integra LifeSciences stock rating to buy, sets $28 target - Investing.com
ALERT: Grabar Law Office Investigates Claims for Long-Term Shareholders of Holley Inc. (NYSE: HLLY); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); and Virtu Financial, Inc. (NASDAQ: VIRT) - Morningstar
Pediatric Neurology Devices Market Worth, $5.8 Billion by 2031 | - openPR.com
Quantbot Technologies LP Sells 64,470 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
IART INVESTOR REMINDER: Hagens Berman, National Trial Attorneys, Encourages Integra LifeSciences (IART) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending - ACCESS Newswire
Alert to Long-Term Shareholders of Holley Inc. (NYSE: - GlobeNewswire
Alert to Long-Term Shareholders of Holley Inc. (NYSE: HLLY); Integra LifeSciences Holdings Corporation (NASDAQ: IART); Outset Medical, Inc. (NASDAQ: OM); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Is Investigating Claims on Your Behal - Morningstar
Winners And Losers Of Q4: Integra LifeSciences (NASDAQ:IART) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
Notice to Long-Term Shareholders of Driven Brands Holdings, - GlobeNewswire
Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Holley Inc. (NYSE: HLLY); Integra LifeSciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Is Investigating Claims On Your Behalf - GlobeNewswire Inc.
Notice to Long-Term Shareholders of Akero Therapeutics, - GlobeNewswire
Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Integra Lifesciences Holdings Corporation (Nasdaq: IART); and Kyverna Therapeutics, Inc. (Nasdaq: KYTX): Grabar Law Office is I - TradingView
Victory Capital Management Inc. Sells 9,832 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Grabar Law Investigates Integra LifeSciences (IART) Board for Potential Fiduciary Breach Amid Securities Fraud Allegations – Apnakal market - Apna Kal
Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders - Bluefield Daily Telegraph
Notice to Long-Term Integra Lifesciences Holdings - GlobeNewswire
Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf - TradingView
PNC Financial Services Group Inc. Boosts Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Charles Schwab Investment Management Inc. Increases Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences Holdings Co. (NASDAQ:IART) Position Lowered by Bank of New York Mellon Corp - Defense World
3 Reasons IART is Risky and 1 Stock to Buy Instead - Yahoo Finance
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - Yahoo Finance
Integra LifeSciences Holdings Corp. to Host Earnings Call - ACCESS Newswire
Amalgamated Bank Has $440,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
How does Integra Lifesciences Holdings Corp (IART) change from a tortoise to a hare? - SETE News
Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up - Yahoo Finance
Decoding Integra Lifesciences Holdings Corp (IART): A Strategic SWOT Insight - GuruFocus
Integra LifeSciences (NASDAQ:IART) Trading Up 5.1%Time to Buy? - MarketBeat
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Investor Network: INTEGRA LIFESCIENCES HOLDINGS CORP to Host Earnings Call - ACCESS Newswire
Integra LifeSciences Holdings Corp Releases 2024 Form 10-K Report: A Comprehensive Analysis of Financial Performance, Business Strategy, and Market Challenges - HPBL
Integra Lifesciences Holdings Corp Azioni (IART) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.01%
0.46%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):